Atovaquone as prophylaxis for Pneumocystis carinii.
Vilar
F J
FJ
McKendrick
M W
MW
Nash
C
C
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000209:etiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D053626:Atovaquone; D018791:CD4 Lymphocyte Count; D005260:Female; D006801:Humans; D009285:Naphthoquinones / Q000008:administration & dosage / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000517:prevention & control*
D000935:Antifungal Agents; D009285:Naphthoquinones; D053626:Atovaquone